GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nr1i3
|
ENSMUSG00000005677.8 | nuclear receptor subfamily 1, group I, member 3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Nr1i3 | mm10_v2_chr1_+_171214013_171214045 | 0.65 | 1.6e-05 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr14_-_34355383 | 18.76 |
ENSMUST00000052126.5
|
Fam25c
|
family with sequence similarity 25, member C |
chr4_-_60582152 | 15.69 |
ENSMUST00000098047.2
|
Mup10
|
major urinary protein 10 |
chr17_-_32917048 | 14.09 |
ENSMUST00000054174.7
|
Cyp4f14
|
cytochrome P450, family 4, subfamily f, polypeptide 14 |
chr5_-_146009598 | 13.59 |
ENSMUST00000138870.1
ENSMUST00000068317.6 |
Cyp3a25
|
cytochrome P450, family 3, subfamily a, polypeptide 25 |
chr4_-_61674094 | 13.55 |
ENSMUST00000098040.3
|
Mup18
|
major urinary protein 18 |
chr4_-_60662358 | 13.49 |
ENSMUST00000084544.4
ENSMUST00000098046.3 |
Mup11
|
major urinary protein 11 |
chr19_+_39007019 | 13.47 |
ENSMUST00000025966.4
|
Cyp2c55
|
cytochrome P450, family 2, subfamily c, polypeptide 55 |
chr4_-_60222580 | 13.12 |
ENSMUST00000095058.4
ENSMUST00000163931.1 |
Mup8
|
major urinary protein 8 |
chr4_-_61303998 | 12.63 |
ENSMUST00000071005.8
ENSMUST00000075206.5 |
Mup14
|
major urinary protein 14 |
chr9_+_46268601 | 12.32 |
ENSMUST00000121598.1
|
Apoa5
|
apolipoprotein A-V |
chr17_-_32917320 | 11.84 |
ENSMUST00000179434.1
|
Cyp4f14
|
cytochrome P450, family 4, subfamily f, polypeptide 14 |
chr4_+_115518264 | 11.79 |
ENSMUST00000058785.3
ENSMUST00000094886.3 |
Cyp4a10
|
cytochrome P450, family 4, subfamily a, polypeptide 10 |
chr7_+_27119909 | 11.43 |
ENSMUST00000003100.8
|
Cyp2f2
|
cytochrome P450, family 2, subfamily f, polypeptide 2 |
chr17_-_31144271 | 10.88 |
ENSMUST00000024826.7
|
Tff2
|
trefoil factor 2 (spasmolytic protein 1) |
chr1_+_166254095 | 10.67 |
ENSMUST00000111416.1
|
Ildr2
|
immunoglobulin-like domain containing receptor 2 |
chr4_+_63344548 | 10.30 |
ENSMUST00000030044.2
|
Orm1
|
orosomucoid 1 |
chr4_-_62087261 | 10.29 |
ENSMUST00000107488.3
ENSMUST00000107472.1 ENSMUST00000084531.4 |
Mup3
|
major urinary protein 3 |
chr6_+_41302265 | 10.19 |
ENSMUST00000031913.4
|
Try4
|
trypsin 4 |
chr4_-_60421933 | 10.10 |
ENSMUST00000107506.2
ENSMUST00000122381.1 ENSMUST00000118759.1 ENSMUST00000122177.1 |
Mup9
|
major urinary protein 9 |
chr8_+_105083753 | 9.87 |
ENSMUST00000093221.6
ENSMUST00000074403.6 |
Ces3b
|
carboxylesterase 3B |
chr15_-_60921270 | 9.80 |
ENSMUST00000096418.3
|
A1bg
|
alpha-1-B glycoprotein |
chr19_-_8405060 | 9.53 |
ENSMUST00000064507.5
ENSMUST00000120540.1 ENSMUST00000096269.4 |
Slc22a30
|
solute carrier family 22, member 30 |
chr19_-_7802578 | 9.46 |
ENSMUST00000120522.1
ENSMUST00000065634.7 |
Slc22a26
|
solute carrier family 22 (organic cation transporter), member 26 |
chr7_+_26808880 | 9.37 |
ENSMUST00000040944.7
|
Cyp2g1
|
cytochrome P450, family 2, subfamily g, polypeptide 1 |
chr1_+_72824482 | 9.31 |
ENSMUST00000047328.4
|
Igfbp2
|
insulin-like growth factor binding protein 2 |
chr4_+_63362443 | 9.28 |
ENSMUST00000075341.3
|
Orm2
|
orosomucoid 2 |
chr4_-_61835185 | 9.00 |
ENSMUST00000082287.2
|
Mup5
|
major urinary protein 5 |
chr4_+_115299046 | 8.86 |
ENSMUST00000084343.3
|
Cyp4a12a
|
cytochrome P450, family 4, subfamily a, polypeptide 12a |
chr8_+_104926237 | 8.63 |
ENSMUST00000034355.4
ENSMUST00000109410.2 |
Ces2e
|
carboxylesterase 2E |
chr17_+_84683113 | 8.62 |
ENSMUST00000045714.8
|
Abcg8
|
ATP-binding cassette, sub-family G (WHITE), member 8 |
chr10_+_79890853 | 8.61 |
ENSMUST00000061653.7
|
Cfd
|
complement factor D (adipsin) |
chr4_-_61303802 | 8.54 |
ENSMUST00000125461.1
|
Mup14
|
major urinary protein 14 |
chr4_-_60139857 | 8.49 |
ENSMUST00000107490.4
ENSMUST00000074700.2 |
Mup2
|
major urinary protein 2 |
chr9_-_46235260 | 8.23 |
ENSMUST00000121916.1
ENSMUST00000034586.2 |
Apoc3
|
apolipoprotein C-III |
chr17_+_84683131 | 8.04 |
ENSMUST00000171915.1
|
Abcg8
|
ATP-binding cassette, sub-family G (WHITE), member 8 |
chr19_+_12633303 | 7.75 |
ENSMUST00000044976.5
|
Glyat
|
glycine-N-acyltransferase |
chr4_-_62054112 | 7.75 |
ENSMUST00000074018.3
|
Mup20
|
major urinary protein 20 |
chr6_-_85869128 | 7.69 |
ENSMUST00000045008.7
|
Cml2
|
camello-like 2 |
chr4_+_115411624 | 7.67 |
ENSMUST00000094887.3
|
Cyp4a12b
|
cytochrome P450, family 4, subfamily a, polypeptide 12B |
chr16_+_91269759 | 7.55 |
ENSMUST00000056882.5
|
Olig1
|
oligodendrocyte transcription factor 1 |
chr3_-_98630309 | 7.49 |
ENSMUST00000044094.4
|
Hsd3b5
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 5 |
chr19_-_8131982 | 7.39 |
ENSMUST00000065651.4
|
Slc22a28
|
solute carrier family 22, member 28 |
chr2_-_25469742 | 7.39 |
ENSMUST00000114259.2
ENSMUST00000015234.6 |
Ptgds
|
prostaglandin D2 synthase (brain) |
chr4_+_115600975 | 7.00 |
ENSMUST00000084342.5
|
Cyp4a32
|
cytochrome P450, family 4, subfamily a, polypeptide 32 |
chr9_+_46269069 | 6.97 |
ENSMUST00000034584.3
|
Apoa5
|
apolipoprotein A-V |
chr5_-_145879857 | 6.97 |
ENSMUST00000035918.7
|
Cyp3a11
|
cytochrome P450, family 3, subfamily a, polypeptide 11 |
chr6_-_138073196 | 6.83 |
ENSMUST00000050132.3
|
Slc15a5
|
solute carrier family 15, member 5 |
chr14_+_69171576 | 6.83 |
ENSMUST00000062437.8
|
Nkx2-6
|
NK2 homeobox 6 |
chr7_+_25897620 | 6.81 |
ENSMUST00000072438.6
ENSMUST00000005477.5 |
Cyp2b10
|
cytochrome P450, family 2, subfamily b, polypeptide 10 |
chr11_-_70514608 | 6.78 |
ENSMUST00000021179.3
|
Vmo1
|
vitelline membrane outer layer 1 homolog (chicken) |
chr10_+_128254131 | 6.58 |
ENSMUST00000060782.3
|
Apon
|
apolipoprotein N |
chr9_-_48605147 | 6.58 |
ENSMUST00000034808.5
ENSMUST00000119426.1 |
Nnmt
|
nicotinamide N-methyltransferase |
chr3_-_107969162 | 6.57 |
ENSMUST00000004136.8
ENSMUST00000106678.1 |
Gstm3
|
glutathione S-transferase, mu 3 |
chr15_+_10314102 | 6.57 |
ENSMUST00000127467.1
|
Prlr
|
prolactin receptor |
chr10_+_127801145 | 6.52 |
ENSMUST00000071646.1
|
Rdh16
|
retinol dehydrogenase 16 |
chr11_-_26210553 | 6.51 |
ENSMUST00000101447.3
|
5730522E02Rik
|
RIKEN cDNA 5730522E02 gene |
chr10_+_127866457 | 6.50 |
ENSMUST00000092058.3
|
BC089597
|
cDNA sequence BC089597 |
chr4_-_63154130 | 6.44 |
ENSMUST00000030041.4
|
Ambp
|
alpha 1 microglobulin/bikunin |
chr11_-_113708952 | 6.43 |
ENSMUST00000106617.1
|
Cpsf4l
|
cleavage and polyadenylation specific factor 4-like |
chr15_+_10223974 | 6.39 |
ENSMUST00000128450.1
ENSMUST00000148257.1 ENSMUST00000128921.1 |
Prlr
|
prolactin receptor |
chr17_-_84682932 | 6.24 |
ENSMUST00000066175.3
|
Abcg5
|
ATP-binding cassette, sub-family G (WHITE), member 5 |
chr1_-_130661584 | 6.18 |
ENSMUST00000137276.2
|
C4bp
|
complement component 4 binding protein |
chr1_-_130661613 | 6.16 |
ENSMUST00000027657.7
|
C4bp
|
complement component 4 binding protein |
chr4_-_42756543 | 6.10 |
ENSMUST00000102957.3
|
Ccl19
|
chemokine (C-C motif) ligand 19 |
chr4_-_59960659 | 6.07 |
ENSMUST00000075973.2
|
Mup4
|
major urinary protein 4 |
chr6_-_5256226 | 6.01 |
ENSMUST00000125686.1
ENSMUST00000031773.2 |
Pon3
|
paraoxonase 3 |
chr2_+_102706356 | 5.98 |
ENSMUST00000123759.1
ENSMUST00000111212.1 ENSMUST00000005220.4 |
Slc1a2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
chr10_+_87859481 | 5.97 |
ENSMUST00000121952.1
|
Igf1
|
insulin-like growth factor 1 |
chr7_-_141276729 | 5.95 |
ENSMUST00000167263.1
ENSMUST00000080654.5 |
Cdhr5
|
cadherin-related family member 5 |
chr11_+_72435565 | 5.85 |
ENSMUST00000100903.2
|
Ggt6
|
gamma-glutamyltransferase 6 |
chr10_+_87859593 | 5.83 |
ENSMUST00000126490.1
|
Igf1
|
insulin-like growth factor 1 |
chr7_-_99695809 | 5.79 |
ENSMUST00000107086.2
|
Slco2b1
|
solute carrier organic anion transporter family, member 2b1 |
chr6_+_90550789 | 5.79 |
ENSMUST00000130418.1
ENSMUST00000032175.8 |
Aldh1l1
|
aldehyde dehydrogenase 1 family, member L1 |
chr3_-_18243289 | 5.76 |
ENSMUST00000035625.6
|
Cyp7b1
|
cytochrome P450, family 7, subfamily b, polypeptide 1 |
chr6_+_90333270 | 5.75 |
ENSMUST00000164761.1
ENSMUST00000046128.9 |
Uroc1
|
urocanase domain containing 1 |
chr10_-_24101951 | 5.72 |
ENSMUST00000170267.1
|
Taar8c
|
trace amine-associated receptor 8C |
chr17_-_78985428 | 5.70 |
ENSMUST00000118991.1
|
Prkd3
|
protein kinase D3 |
chr4_-_62150810 | 5.68 |
ENSMUST00000077719.3
|
Mup21
|
major urinary protein 21 |
chr2_+_173153048 | 5.63 |
ENSMUST00000029017.5
|
Pck1
|
phosphoenolpyruvate carboxykinase 1, cytosolic |
chr9_-_65422773 | 5.56 |
ENSMUST00000065894.5
|
Slc51b
|
solute carrier family 51, beta subunit |
chr1_-_140183404 | 5.53 |
ENSMUST00000066859.6
ENSMUST00000111976.2 |
Cfh
|
complement component factor h |
chr11_+_70054334 | 5.50 |
ENSMUST00000018699.6
ENSMUST00000108585.2 |
Asgr1
|
asialoglycoprotein receptor 1 |
chr1_-_139781236 | 5.47 |
ENSMUST00000027612.8
ENSMUST00000111989.2 ENSMUST00000111986.2 |
Gm4788
|
predicted gene 4788 |
chr10_+_87521920 | 5.47 |
ENSMUST00000142088.1
|
Pah
|
phenylalanine hydroxylase |
chr9_-_57683644 | 5.46 |
ENSMUST00000034860.3
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2 |
chr9_-_46235631 | 5.41 |
ENSMUST00000118649.1
|
Apoc3
|
apolipoprotein C-III |
chr4_+_60003438 | 5.41 |
ENSMUST00000107517.1
ENSMUST00000107520.1 |
Mup6
|
major urinary protein 6 |
chr17_+_24878724 | 5.39 |
ENSMUST00000050714.6
|
Igfals
|
insulin-like growth factor binding protein, acid labile subunit |
chr1_-_139560158 | 5.38 |
ENSMUST00000160423.1
ENSMUST00000023965.5 |
Cfhr1
|
complement factor H-related 1 |
chr7_-_105600103 | 5.35 |
ENSMUST00000033185.8
|
Hpx
|
hemopexin |
chr8_+_105048592 | 5.35 |
ENSMUST00000093222.5
ENSMUST00000093223.3 |
Ces3a
|
carboxylesterase 3A |
chr4_-_60741275 | 5.34 |
ENSMUST00000117932.1
|
Mup12
|
major urinary protein 12 |
chr19_-_11081088 | 5.34 |
ENSMUST00000025636.6
|
Ms4a8a
|
membrane-spanning 4-domains, subfamily A, member 8A |
chr1_-_140183283 | 5.33 |
ENSMUST00000111977.1
|
Cfh
|
complement component factor h |
chr12_+_112106683 | 5.31 |
ENSMUST00000079400.4
|
Aspg
|
asparaginase homolog (S. cerevisiae) |
chr9_+_46240696 | 5.31 |
ENSMUST00000034585.6
|
Apoa4
|
apolipoprotein A-IV |
chr1_-_180193653 | 5.29 |
ENSMUST00000159914.1
|
Adck3
|
aarF domain containing kinase 3 |
chr5_-_137921612 | 5.25 |
ENSMUST00000031741.7
|
Cyp3a13
|
cytochrome P450, family 3, subfamily a, polypeptide 13 |
chr9_-_15301555 | 5.24 |
ENSMUST00000034414.8
|
4931406C07Rik
|
RIKEN cDNA 4931406C07 gene |
chr4_-_19922599 | 5.23 |
ENSMUST00000029900.5
|
Atp6v0d2
|
ATPase, H+ transporting, lysosomal V0 subunit D2 |
chr10_+_87521795 | 5.22 |
ENSMUST00000020241.8
|
Pah
|
phenylalanine hydroxylase |
chr1_+_131797381 | 5.21 |
ENSMUST00000112393.2
ENSMUST00000048660.5 |
Pm20d1
|
peptidase M20 domain containing 1 |
chr5_+_146079254 | 5.14 |
ENSMUST00000035571.8
|
Cyp3a59
|
cytochrome P450, family 3, subfamily a, polypeptide 59 |
chr4_+_42629719 | 5.10 |
ENSMUST00000166898.2
|
Gm2564
|
predicted gene 2564 |
chr1_+_78511865 | 5.02 |
ENSMUST00000012331.6
|
Mogat1
|
monoacylglycerol O-acyltransferase 1 |
chr5_-_116422858 | 4.98 |
ENSMUST00000036991.4
|
Hspb8
|
heat shock protein 8 |
chr15_+_99393610 | 4.95 |
ENSMUST00000159531.1
|
Tmbim6
|
transmembrane BAX inhibitor motif containing 6 |
chr16_-_18413452 | 4.94 |
ENSMUST00000165430.1
ENSMUST00000147720.1 |
Comt
|
catechol-O-methyltransferase |
chr6_-_138079916 | 4.94 |
ENSMUST00000171804.1
|
Slc15a5
|
solute carrier family 15, member 5 |
chr8_+_104867488 | 4.92 |
ENSMUST00000043209.9
|
Ces2d-ps
|
carboxylesterase 2D, pseudogene |
chr8_+_104847061 | 4.89 |
ENSMUST00000055052.5
|
Ces2c
|
carboxylesterase 2C |
chr10_+_87860030 | 4.87 |
ENSMUST00000062862.6
|
Igf1
|
insulin-like growth factor 1 |
chr7_-_30973464 | 4.87 |
ENSMUST00000001279.8
|
Lsr
|
lipolysis stimulated lipoprotein receptor |
chr15_+_99393574 | 4.84 |
ENSMUST00000162624.1
|
Tmbim6
|
transmembrane BAX inhibitor motif containing 6 |
chr18_+_45268876 | 4.82 |
ENSMUST00000183850.1
ENSMUST00000066890.7 |
Kcnn2
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2 |
chr15_+_100353149 | 4.82 |
ENSMUST00000075675.5
ENSMUST00000088142.5 ENSMUST00000176287.1 |
AB099516
Mettl7a2
|
cDNA sequence AB099516 methyltransferase like 7A2 |
chr2_+_122147680 | 4.82 |
ENSMUST00000102476.4
|
B2m
|
beta-2 microglobulin |
chr10_-_127370535 | 4.77 |
ENSMUST00000026472.8
|
Inhbc
|
inhibin beta-C |
chr19_+_20601958 | 4.76 |
ENSMUST00000087638.3
|
Aldh1a1
|
aldehyde dehydrogenase family 1, subfamily A1 |
chr1_-_180193475 | 4.72 |
ENSMUST00000160482.1
ENSMUST00000170472.1 |
Adck3
|
aarF domain containing kinase 3 |
chr5_-_87337165 | 4.69 |
ENSMUST00000031195.2
|
Ugt2a3
|
UDP glucuronosyltransferase 2 family, polypeptide A3 |
chr10_-_109010955 | 4.66 |
ENSMUST00000105276.1
ENSMUST00000064054.7 |
Syt1
|
synaptotagmin I |
chr13_+_24845122 | 4.66 |
ENSMUST00000006893.8
|
D130043K22Rik
|
RIKEN cDNA D130043K22 gene |
chr13_+_4436094 | 4.65 |
ENSMUST00000156277.1
|
Akr1c6
|
aldo-keto reductase family 1, member C6 |
chr2_-_25501717 | 4.64 |
ENSMUST00000015227.3
|
C8g
|
complement component 8, gamma polypeptide |
chr2_+_71981184 | 4.61 |
ENSMUST00000090826.5
ENSMUST00000102698.3 |
Rapgef4
|
Rap guanine nucleotide exchange factor (GEF) 4 |
chr7_-_48848023 | 4.57 |
ENSMUST00000032658.6
|
Csrp3
|
cysteine and glycine-rich protein 3 |
chr11_+_72435511 | 4.55 |
ENSMUST00000076443.3
|
Ggt6
|
gamma-glutamyltransferase 6 |
chr1_+_87264345 | 4.52 |
ENSMUST00000118687.1
ENSMUST00000027472.6 |
Efhd1
|
EF hand domain containing 1 |
chr8_+_104733997 | 4.47 |
ENSMUST00000034346.8
ENSMUST00000164182.2 |
Ces2a
|
carboxylesterase 2A |
chr7_+_13623967 | 4.47 |
ENSMUST00000108525.2
|
Sult2a5
|
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 5 |
chr7_+_44225430 | 4.41 |
ENSMUST00000075162.3
|
Klk1
|
kallikrein 1 |
chr15_-_89373810 | 4.39 |
ENSMUST00000167643.2
|
Sco2
|
SCO cytochrome oxidase deficient homolog 2 (yeast) |
chr14_+_66140919 | 4.39 |
ENSMUST00000022620.9
|
Chrna2
|
cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal) |
chr15_+_102445367 | 4.38 |
ENSMUST00000023809.4
|
Amhr2
|
anti-Mullerian hormone type 2 receptor |
chr9_-_22002599 | 4.38 |
ENSMUST00000115336.2
ENSMUST00000044926.5 |
Ccdc151
|
coiled-coil domain containing 151 |
chr5_+_92387846 | 4.36 |
ENSMUST00000138687.1
ENSMUST00000124509.1 |
Art3
|
ADP-ribosyltransferase 3 |
chr11_-_58613481 | 4.33 |
ENSMUST00000048801.7
|
2210407C18Rik
|
RIKEN cDNA 2210407C18 gene |
chr7_-_140154712 | 4.32 |
ENSMUST00000059241.7
|
Sprn
|
shadow of prion protein |
chr1_+_9547948 | 4.31 |
ENSMUST00000144177.1
|
Adhfe1
|
alcohol dehydrogenase, iron containing, 1 |
chr7_-_139582790 | 4.28 |
ENSMUST00000106095.2
|
Nkx6-2
|
NK6 homeobox 2 |
chr1_+_88106834 | 4.27 |
ENSMUST00000113137.1
|
Ugt1a6b
|
UDP glucuronosyltransferase 1 family, polypeptide A6B |
chr7_-_19698206 | 4.22 |
ENSMUST00000172808.1
ENSMUST00000174191.1 |
Apoe
|
apolipoprotein E |
chr5_-_24758008 | 4.20 |
ENSMUST00000047119.4
|
Crygn
|
crystallin, gamma N |
chr7_+_44216456 | 4.19 |
ENSMUST00000074359.2
|
Klk1b5
|
kallikrein 1-related peptidase b5 |
chr11_+_72435534 | 4.18 |
ENSMUST00000108499.1
|
Ggt6
|
gamma-glutamyltransferase 6 |
chr1_-_51915968 | 4.12 |
ENSMUST00000046390.7
|
Myo1b
|
myosin IB |
chr11_-_120661175 | 4.10 |
ENSMUST00000150458.1
|
Notum
|
notum pectinacetylesterase homolog (Drosophila) |
chr7_-_30973367 | 4.06 |
ENSMUST00000108116.3
|
Lsr
|
lipolysis stimulated lipoprotein receptor |
chr7_-_141010759 | 3.98 |
ENSMUST00000026565.6
|
Ifitm3
|
interferon induced transmembrane protein 3 |
chr6_+_72636244 | 3.98 |
ENSMUST00000101278.2
|
Gm15401
|
predicted gene 15401 |
chr11_+_75510077 | 3.97 |
ENSMUST00000042972.6
|
Rilp
|
Rab interacting lysosomal protein |
chr10_+_80329953 | 3.96 |
ENSMUST00000105358.1
ENSMUST00000105357.1 ENSMUST00000105354.1 ENSMUST00000105355.1 |
Reep6
|
receptor accessory protein 6 |
chr10_+_87859255 | 3.96 |
ENSMUST00000105300.2
|
Igf1
|
insulin-like growth factor 1 |
chr9_-_51963533 | 3.95 |
ENSMUST00000034552.6
|
Fdx1
|
ferredoxin 1 |
chr10_+_87521954 | 3.93 |
ENSMUST00000143624.1
|
Pah
|
phenylalanine hydroxylase |
chr19_-_8218832 | 3.93 |
ENSMUST00000113298.2
|
Slc22a29
|
solute carrier family 22. member 29 |
chr2_-_25470031 | 3.92 |
ENSMUST00000114251.1
|
Ptgds
|
prostaglandin D2 synthase (brain) |
chr2_-_27247260 | 3.91 |
ENSMUST00000102886.3
ENSMUST00000129975.1 |
Sardh
|
sarcosine dehydrogenase |
chr6_+_42245907 | 3.88 |
ENSMUST00000031897.5
|
Gstk1
|
glutathione S-transferase kappa 1 |
chr2_+_105224314 | 3.86 |
ENSMUST00000068813.2
|
0610012H03Rik
|
RIKEN cDNA 0610012H03 gene |
chr16_+_5007283 | 3.85 |
ENSMUST00000184439.1
|
Smim22
|
small integral membrane protein 22 |
chr11_-_116198701 | 3.82 |
ENSMUST00000072948.4
|
Acox1
|
acyl-Coenzyme A oxidase 1, palmitoyl |
chr3_+_135281221 | 3.82 |
ENSMUST00000120397.1
ENSMUST00000171974.1 ENSMUST00000029817.7 |
Bdh2
|
3-hydroxybutyrate dehydrogenase, type 2 |
chr7_+_140845562 | 3.81 |
ENSMUST00000035300.5
|
Scgb1c1
|
secretoglobin, family 1C, member 1 |
chr7_-_14492926 | 3.80 |
ENSMUST00000108524.3
|
Sult2a7
|
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 7 |
chr19_-_46672883 | 3.79 |
ENSMUST00000026012.7
|
Cyp17a1
|
cytochrome P450, family 17, subfamily a, polypeptide 1 |
chr2_+_102659213 | 3.79 |
ENSMUST00000111213.1
|
Slc1a2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
chr15_+_7129557 | 3.77 |
ENSMUST00000067190.5
ENSMUST00000164529.1 |
Lifr
|
leukemia inhibitory factor receptor |
chr7_-_132576372 | 3.77 |
ENSMUST00000084500.6
|
Oat
|
ornithine aminotransferase |
chr11_-_77519186 | 3.75 |
ENSMUST00000100807.2
|
Gm10392
|
predicted gene 10392 |
chr2_+_58755177 | 3.75 |
ENSMUST00000102755.3
|
Upp2
|
uridine phosphorylase 2 |
chr9_-_21989427 | 3.68 |
ENSMUST00000045726.6
|
Rgl3
|
ral guanine nucleotide dissociation stimulator-like 3 |
chr9_+_107340593 | 3.66 |
ENSMUST00000042581.2
|
6430571L13Rik
|
RIKEN cDNA 6430571L13 gene |
chr17_-_56005566 | 3.65 |
ENSMUST00000043785.6
|
Stap2
|
signal transducing adaptor family member 2 |
chr9_+_44107268 | 3.65 |
ENSMUST00000114821.2
ENSMUST00000114818.2 |
C1qtnf5
|
C1q and tumor necrosis factor related protein 5 |
chr10_+_62071014 | 3.64 |
ENSMUST00000053865.5
|
Gm5424
|
predicted gene 5424 |
chr19_+_39992424 | 3.64 |
ENSMUST00000049178.2
|
Cyp2c37
|
cytochrome P450, family 2. subfamily c, polypeptide 37 |
chr8_+_119437118 | 3.63 |
ENSMUST00000152420.1
ENSMUST00000098365.3 |
Osgin1
|
oxidative stress induced growth inhibitor 1 |
chr10_+_61720592 | 3.60 |
ENSMUST00000080099.5
|
Aifm2
|
apoptosis-inducing factor, mitochondrion-associated 2 |
chr9_+_123150941 | 3.59 |
ENSMUST00000026890.4
|
Clec3b
|
C-type lectin domain family 3, member b |
chr5_-_113081579 | 3.57 |
ENSMUST00000131708.1
ENSMUST00000117143.1 ENSMUST00000119627.1 |
Crybb3
|
crystallin, beta B3 |
chr4_-_41503046 | 3.56 |
ENSMUST00000054920.4
|
AI464131
|
expressed sequence AI464131 |
chr6_-_124917939 | 3.56 |
ENSMUST00000032216.6
|
Ptms
|
parathymosin |
chr4_-_137409777 | 3.55 |
ENSMUST00000024200.6
|
Gm13011
|
predicted gene 13011 |
chr11_+_101367542 | 3.54 |
ENSMUST00000019469.2
|
G6pc
|
glucose-6-phosphatase, catalytic |
chr10_+_128194446 | 3.53 |
ENSMUST00000044776.6
|
Gls2
|
glutaminase 2 (liver, mitochondrial) |
chr2_+_68104671 | 3.53 |
ENSMUST00000042456.3
|
B3galt1
|
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1 |
chr11_-_5950018 | 3.51 |
ENSMUST00000102920.3
|
Gck
|
glucokinase |
chr1_+_88166004 | 3.51 |
ENSMUST00000097659.4
|
Ugt1a5
|
UDP glucuronosyltransferase 1 family, polypeptide A5 |
chr7_-_30973399 | 3.48 |
ENSMUST00000098553.4
ENSMUST00000147431.1 |
Lsr
|
lipolysis stimulated lipoprotein receptor |
chr5_-_87424201 | 3.47 |
ENSMUST00000072818.5
|
Ugt2b38
|
UDP glucuronosyltransferase 2 family, polypeptide B38 |
chr15_-_34495180 | 3.46 |
ENSMUST00000022946.5
|
Hrsp12
|
heat-responsive protein 12 |
chr12_-_103773592 | 3.45 |
ENSMUST00000078869.5
|
Serpina1d
|
serine (or cysteine) peptidase inhibitor, clade A, member 1D |
chr6_+_72598475 | 3.44 |
ENSMUST00000070597.6
ENSMUST00000176364.1 ENSMUST00000176168.1 |
Retsat
|
retinol saturase (all trans retinol 13,14 reductase) |
chr9_+_108080436 | 3.44 |
ENSMUST00000035211.7
ENSMUST00000162886.1 |
Mst1
|
macrophage stimulating 1 (hepatocyte growth factor-like) |
chr11_+_60728398 | 3.43 |
ENSMUST00000018743.4
|
Mief2
|
mitochondrial elongation factor 2 |
chr8_-_45333189 | 3.43 |
ENSMUST00000095328.4
|
Cyp4v3
|
cytochrome P450, family 4, subfamily v, polypeptide 3 |
chr4_-_137430517 | 3.42 |
ENSMUST00000102522.4
|
Cela3b
|
chymotrypsin-like elastase family, member 3B |
chr7_+_44384098 | 3.41 |
ENSMUST00000118962.1
ENSMUST00000118831.1 |
Syt3
|
synaptotagmin III |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.6 | 22.9 | GO:0060752 | negative regulation of intestinal phytosterol absorption(GO:0010949) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) negative regulation of intestinal lipid absorption(GO:1904730) |
5.1 | 20.5 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
4.9 | 14.6 | GO:0009073 | tyrosine biosynthetic process(GO:0006571) aromatic amino acid family biosynthetic process(GO:0009073) aromatic amino acid family biosynthetic process, prephenate pathway(GO:0009095) |
4.1 | 12.4 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
3.7 | 14.8 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
3.4 | 20.6 | GO:1904073 | regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
3.2 | 12.7 | GO:0042196 | chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
3.0 | 9.1 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
2.6 | 7.8 | GO:0061402 | positive regulation of transcription from RNA polymerase II promoter in response to acidic pH(GO:0061402) |
2.6 | 12.9 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
2.4 | 38.3 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
2.3 | 16.0 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
2.3 | 6.8 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
2.2 | 13.0 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
2.1 | 2.1 | GO:0038190 | neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) |
2.1 | 6.3 | GO:2000547 | regulation of dendritic cell dendrite assembly(GO:2000547) |
2.1 | 4.1 | GO:0006507 | GPI anchor release(GO:0006507) |
2.0 | 6.0 | GO:0009804 | coumarin metabolic process(GO:0009804) phenylpropanoid catabolic process(GO:0046271) |
2.0 | 9.8 | GO:0031437 | regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
1.9 | 5.8 | GO:0009397 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
1.9 | 15.1 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
1.9 | 11.3 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
1.8 | 25.8 | GO:0015747 | urate transport(GO:0015747) |
1.6 | 4.9 | GO:0031335 | regulation of sulfur amino acid metabolic process(GO:0031335) |
1.6 | 14.6 | GO:0035754 | B cell chemotaxis(GO:0035754) |
1.6 | 8.0 | GO:0015886 | heme transport(GO:0015886) |
1.6 | 4.7 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
1.6 | 4.7 | GO:0042823 | pyridoxal phosphate biosynthetic process(GO:0042823) |
1.6 | 1.6 | GO:0002489 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
1.5 | 4.6 | GO:0071395 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
1.5 | 10.8 | GO:0052805 | imidazole-containing compound catabolic process(GO:0052805) |
1.5 | 4.6 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
1.5 | 4.6 | GO:1903918 | regulation of actin filament severing(GO:1903918) negative regulation of actin filament severing(GO:1903919) |
1.4 | 5.8 | GO:0071718 | sodium-independent icosanoid transport(GO:0071718) |
1.4 | 4.2 | GO:1903000 | regulation of lipid transport across blood brain barrier(GO:1903000) positive regulation of lipid transport across blood brain barrier(GO:1903002) |
1.4 | 2.8 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
1.4 | 1.4 | GO:0050787 | detoxification of mercury ion(GO:0050787) |
1.4 | 9.8 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.4 | 13.9 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
1.3 | 4.0 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
1.3 | 4.0 | GO:0015755 | fructose transport(GO:0015755) |
1.3 | 10.5 | GO:0006004 | fucose metabolic process(GO:0006004) |
1.3 | 3.9 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
1.3 | 7.7 | GO:0008355 | olfactory learning(GO:0008355) |
1.3 | 6.4 | GO:1904970 | brush border assembly(GO:1904970) |
1.3 | 8.8 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
1.2 | 1.2 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
1.2 | 1.2 | GO:0036482 | neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036482) positive regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902958) regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903383) negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903384) |
1.2 | 4.6 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
1.1 | 4.6 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
1.1 | 4.5 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
1.1 | 12.4 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
1.1 | 2.2 | GO:0046439 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
1.1 | 6.6 | GO:0006543 | glutamine catabolic process(GO:0006543) |
1.1 | 5.4 | GO:0052695 | cellular glucuronidation(GO:0052695) |
1.1 | 14.1 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
1.0 | 6.3 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
1.0 | 3.1 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
1.0 | 7.2 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
1.0 | 2.0 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
1.0 | 4.0 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
1.0 | 5.0 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
1.0 | 1.0 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
1.0 | 2.9 | GO:0006553 | lysine metabolic process(GO:0006553) |
1.0 | 2.9 | GO:0010716 | negative regulation of extracellular matrix disassembly(GO:0010716) |
1.0 | 2.9 | GO:0061290 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
0.9 | 20.7 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.9 | 5.6 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.9 | 1.8 | GO:1903179 | regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
0.9 | 8.3 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.9 | 3.6 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.9 | 5.3 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.9 | 2.6 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.9 | 3.4 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.8 | 9.3 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.8 | 2.5 | GO:0035973 | aggrephagy(GO:0035973) |
0.8 | 2.5 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.8 | 9.8 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.8 | 5.7 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.8 | 2.4 | GO:0006583 | melanin biosynthetic process from tyrosine(GO:0006583) |
0.8 | 2.4 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) |
0.8 | 4.0 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.8 | 3.2 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.8 | 4.8 | GO:1902998 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
0.8 | 4.8 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.8 | 7.2 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.8 | 7.9 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.8 | 4.0 | GO:0033762 | response to glucagon(GO:0033762) |
0.8 | 3.1 | GO:0099527 | postsynapse to nucleus signaling pathway(GO:0099527) |
0.8 | 6.2 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.8 | 0.8 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.8 | 1.5 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
0.8 | 2.3 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.8 | 3.8 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.8 | 5.3 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.8 | 3.8 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.8 | 3.0 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.8 | 2.3 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
0.7 | 2.2 | GO:0043181 | vacuolar sequestering(GO:0043181) |
0.7 | 2.2 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.7 | 4.4 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.7 | 3.7 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.7 | 9.3 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.7 | 18.5 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.7 | 1.4 | GO:0055095 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.7 | 3.5 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.7 | 2.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.7 | 4.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.7 | 16.7 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.7 | 2.8 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.7 | 4.1 | GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
0.7 | 2.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.7 | 2.7 | GO:0006001 | fructose catabolic process(GO:0006001) response to sucrose(GO:0009744) response to disaccharide(GO:0034285) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.7 | 2.7 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.7 | 2.7 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) |
0.7 | 2.0 | GO:0042091 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.7 | 2.0 | GO:1900245 | negative regulation of MDA-5 signaling pathway(GO:0039534) positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.6 | 1.9 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
0.6 | 1.9 | GO:0046949 | fatty-acyl-CoA biosynthetic process(GO:0046949) malonyl-CoA metabolic process(GO:2001293) |
0.6 | 3.8 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.6 | 4.4 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.6 | 3.2 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.6 | 1.9 | GO:0070949 | neutrophil mediated killing of fungus(GO:0070947) regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.6 | 6.3 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.6 | 3.1 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.6 | 2.5 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.6 | 2.5 | GO:1901373 | positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) |
0.6 | 4.3 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.6 | 4.3 | GO:0021539 | subthalamus development(GO:0021539) |
0.6 | 5.4 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.6 | 7.2 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.6 | 2.4 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.6 | 3.5 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.6 | 2.3 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.6 | 1.7 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.6 | 5.2 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.6 | 2.9 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.6 | 1.7 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.6 | 1.7 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.6 | 1.7 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.6 | 1.1 | GO:0002740 | negative regulation of cytokine secretion involved in immune response(GO:0002740) |
0.6 | 2.8 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.5 | 2.2 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.5 | 4.9 | GO:0071569 | protein ufmylation(GO:0071569) |
0.5 | 4.9 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.5 | 1.6 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.5 | 2.2 | GO:0046210 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
0.5 | 1.6 | GO:0061193 | taste bud development(GO:0061193) |
0.5 | 3.8 | GO:0034214 | protein hexamerization(GO:0034214) |
0.5 | 1.1 | GO:0097325 | lateral sprouting involved in mammary gland duct morphogenesis(GO:0060599) melanocyte proliferation(GO:0097325) |
0.5 | 1.6 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.5 | 1.6 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.5 | 3.2 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
0.5 | 3.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.5 | 2.6 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.5 | 2.6 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.5 | 19.7 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.5 | 2.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.5 | 3.6 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.5 | 24.2 | GO:0006953 | acute-phase response(GO:0006953) |
0.5 | 2.0 | GO:0006068 | ethanol catabolic process(GO:0006068) ethanol oxidation(GO:0006069) formaldehyde catabolic process(GO:0046294) |
0.5 | 2.0 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.5 | 1.5 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.5 | 2.5 | GO:0032902 | nerve growth factor production(GO:0032902) |
0.5 | 2.0 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.5 | 2.0 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.5 | 2.4 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.5 | 1.5 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.5 | 3.4 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.5 | 3.8 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.5 | 1.0 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.5 | 2.8 | GO:1903275 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
0.5 | 1.9 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.5 | 1.4 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.5 | 3.2 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.5 | 1.4 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.5 | 3.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.5 | 2.3 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.5 | 1.4 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
0.4 | 1.8 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.4 | 2.2 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.4 | 1.8 | GO:0060448 | neuropeptide catabolic process(GO:0010813) dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.4 | 1.8 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.4 | 2.2 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
0.4 | 4.8 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.4 | 1.7 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.4 | 0.4 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.4 | 3.4 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.4 | 6.8 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.4 | 1.3 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.4 | 3.0 | GO:0015862 | uridine transport(GO:0015862) |
0.4 | 1.3 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
0.4 | 3.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.4 | 4.1 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.4 | 17.5 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.4 | 1.2 | GO:1990168 | protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
0.4 | 2.0 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.4 | 3.5 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.4 | 1.2 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.4 | 1.2 | GO:0090285 | regulation of protein glycosylation in Golgi(GO:0090283) negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.4 | 1.9 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.4 | 0.8 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.4 | 3.4 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.4 | 1.9 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.4 | 1.5 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.4 | 6.0 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.4 | 2.3 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.4 | 1.5 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.4 | 2.2 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.4 | 2.2 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.4 | 1.5 | GO:0036367 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
0.4 | 1.5 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.4 | 0.7 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.4 | 1.8 | GO:0042637 | catagen(GO:0042637) |
0.4 | 1.1 | GO:1903048 | regulation of acetylcholine-gated cation channel activity(GO:1903048) |
0.4 | 1.8 | GO:0072181 | mesonephric duct formation(GO:0072181) |
0.4 | 1.8 | GO:0090487 | toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
0.4 | 2.5 | GO:0019532 | oxalate transport(GO:0019532) |
0.4 | 2.1 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
0.4 | 1.4 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.3 | 1.4 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.3 | 3.5 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.3 | 22.1 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.3 | 1.0 | GO:0043323 | positive regulation of natural killer cell degranulation(GO:0043323) |
0.3 | 1.4 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.3 | 2.0 | GO:0014850 | response to muscle activity(GO:0014850) |
0.3 | 2.0 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.3 | 4.0 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.3 | 1.3 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.3 | 1.3 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.3 | 1.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.3 | 1.0 | GO:0061181 | regulation of chondrocyte development(GO:0061181) |
0.3 | 2.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.3 | 3.5 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.3 | 1.3 | GO:0090126 | protein complex assembly involved in synapse maturation(GO:0090126) |
0.3 | 1.0 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.3 | 4.5 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.3 | 7.0 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.3 | 1.3 | GO:0015744 | succinate transport(GO:0015744) |
0.3 | 0.9 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.3 | 1.6 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
0.3 | 1.3 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.3 | 5.3 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.3 | 0.9 | GO:2001200 | positive regulation of dendritic cell differentiation(GO:2001200) |
0.3 | 1.2 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.3 | 1.2 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.3 | 1.2 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.3 | 1.2 | GO:0021660 | rhombomere formation(GO:0021594) rhombomere 3 formation(GO:0021660) rhombomere 5 morphogenesis(GO:0021664) rhombomere 5 formation(GO:0021666) |
0.3 | 1.5 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.3 | 2.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.3 | 1.2 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.3 | 0.9 | GO:0019323 | pentose catabolic process(GO:0019323) |
0.3 | 0.6 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.3 | 3.3 | GO:0072189 | ureter development(GO:0072189) |
0.3 | 1.2 | GO:1903760 | regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) |
0.3 | 0.9 | GO:0050904 | diapedesis(GO:0050904) |
0.3 | 2.3 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.3 | 1.2 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.3 | 0.9 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.3 | 1.7 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.3 | 1.2 | GO:0097494 | regulation of vesicle size(GO:0097494) |
0.3 | 0.9 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.3 | 1.1 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.3 | 0.6 | GO:0033577 | protein glycosylation in endoplasmic reticulum(GO:0033577) |
0.3 | 1.4 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.3 | 1.1 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
0.3 | 1.4 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.3 | 3.9 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.3 | 1.1 | GO:0035552 | oxidative single-stranded DNA demethylation(GO:0035552) oxidative single-stranded RNA demethylation(GO:0035553) |
0.3 | 0.8 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.3 | 0.8 | GO:0021933 | radial glia guided migration of cerebellar granule cell(GO:0021933) |
0.3 | 0.8 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
0.3 | 1.9 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.3 | 4.9 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.3 | 0.8 | GO:0050973 | detection of mechanical stimulus involved in equilibrioception(GO:0050973) |
0.3 | 2.4 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.3 | 1.6 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.3 | 1.3 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.3 | 3.4 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.3 | 0.5 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.3 | 1.1 | GO:0002587 | negative regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002587) |
0.3 | 0.8 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.3 | 0.8 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.3 | 0.8 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.3 | 2.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.3 | 0.8 | GO:0021893 | cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
0.3 | 0.8 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.3 | 3.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.3 | 0.8 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.3 | 1.0 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
0.3 | 1.0 | GO:0030091 | protein repair(GO:0030091) |
0.3 | 3.1 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.3 | 2.5 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.3 | 1.0 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.3 | 1.0 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.3 | 4.0 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.2 | 1.0 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.2 | 0.2 | GO:0009838 | abscission(GO:0009838) |
0.2 | 2.0 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.2 | 3.0 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.2 | 2.7 | GO:0097421 | liver regeneration(GO:0097421) |
0.2 | 3.4 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.2 | 9.4 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.2 | 0.7 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.2 | 6.7 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 1.0 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.2 | 2.9 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 1.0 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.2 | 3.1 | GO:0006956 | complement activation(GO:0006956) |
0.2 | 0.9 | GO:0070163 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
0.2 | 0.7 | GO:1990927 | calcium ion regulated lysosome exocytosis(GO:1990927) |
0.2 | 0.9 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 0.7 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.2 | 1.6 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.2 | 1.2 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.2 | 0.2 | GO:0060460 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.2 | 1.6 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.2 | 2.1 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.2 | 2.3 | GO:0033866 | coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.2 | 0.7 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.2 | 0.5 | GO:0021730 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) |
0.2 | 0.5 | GO:0002188 | translation reinitiation(GO:0002188) |
0.2 | 2.0 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.2 | 0.7 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.2 | 3.2 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.2 | 7.6 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.2 | 0.7 | GO:0001193 | maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
0.2 | 1.7 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.2 | 0.9 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.2 | 0.4 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.2 | 0.9 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.2 | 2.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.2 | 0.9 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.2 | 1.1 | GO:0032439 | endosome localization(GO:0032439) |
0.2 | 2.8 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.2 | 0.8 | GO:0045872 | regulation of rhodopsin gene expression(GO:0007468) positive regulation of rhodopsin gene expression(GO:0045872) |
0.2 | 2.9 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.2 | 1.3 | GO:0046490 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
0.2 | 1.3 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.2 | 0.6 | GO:0031038 | myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
0.2 | 0.2 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.2 | 0.6 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.2 | 2.0 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.2 | 0.8 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.2 | 0.8 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.2 | 3.9 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.2 | 4.7 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.2 | 1.4 | GO:0030242 | pexophagy(GO:0030242) |
0.2 | 0.8 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.2 | 0.6 | GO:0060056 | mammary gland involution(GO:0060056) |
0.2 | 1.2 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.2 | 0.6 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.2 | 5.1 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.2 | 0.8 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.2 | 2.1 | GO:0046415 | urate metabolic process(GO:0046415) |
0.2 | 0.8 | GO:0061724 | lipophagy(GO:0061724) |
0.2 | 1.9 | GO:0060283 | negative regulation of oocyte development(GO:0060283) |
0.2 | 3.1 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
0.2 | 4.0 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.2 | 0.6 | GO:0042117 | monocyte activation(GO:0042117) |
0.2 | 1.3 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.2 | 1.0 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.2 | 2.9 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.2 | 1.1 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.2 | 1.3 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.2 | 0.8 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.2 | 1.7 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.2 | 0.9 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.2 | 1.1 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.2 | 2.6 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.2 | 2.2 | GO:0008272 | sulfate transport(GO:0008272) |
0.2 | 0.7 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.2 | 2.0 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.2 | 0.7 | GO:0090282 | positive regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071931) positive regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0090282) |
0.2 | 0.7 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.2 | 0.9 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.2 | 0.9 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.2 | 0.4 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.2 | 0.5 | GO:0099526 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
0.2 | 1.4 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.2 | 2.7 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.2 | 1.9 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.2 | 2.1 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.2 | 2.3 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.2 | 4.0 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.2 | 2.3 | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
0.2 | 1.2 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.2 | 0.7 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.2 | 1.2 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.2 | 0.9 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) |
0.2 | 0.9 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.2 | 2.0 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.2 | 0.5 | GO:0048840 | otolith development(GO:0048840) |
0.2 | 1.0 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 1.3 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.2 | 0.8 | GO:0021764 | amygdala development(GO:0021764) |
0.2 | 2.7 | GO:0051923 | sulfation(GO:0051923) |
0.2 | 1.2 | GO:0097475 | motor neuron migration(GO:0097475) |
0.2 | 2.3 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.2 | 1.0 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.2 | 0.7 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.2 | 1.5 | GO:0033227 | dsRNA transport(GO:0033227) |
0.2 | 0.7 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.2 | 1.8 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.2 | 0.2 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.2 | 1.1 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.2 | 1.1 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.2 | 1.0 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.2 | 0.8 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.2 | 1.1 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.2 | 1.6 | GO:0006465 | signal peptide processing(GO:0006465) |
0.2 | 0.8 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.2 | 0.6 | GO:0051311 | male meiosis chromosome segregation(GO:0007060) positive regulation of isotype switching to IgA isotypes(GO:0048298) meiotic metaphase plate congression(GO:0051311) |
0.2 | 3.6 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.2 | 0.6 | GO:0007525 | somatic muscle development(GO:0007525) |
0.2 | 6.4 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.2 | 1.1 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.2 | 2.0 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.2 | 0.9 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.2 | 0.6 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.2 | 0.8 | GO:0019359 | nicotinamide nucleotide biosynthetic process(GO:0019359) |
0.2 | 1.2 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.2 | 0.6 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.2 | 0.3 | GO:0036343 | psychomotor behavior(GO:0036343) |
0.2 | 1.4 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
0.2 | 1.7 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 1.9 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.1 | 0.1 | GO:1902460 | mesenchymal stem cell proliferation(GO:0097168) regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.1 | 1.0 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.1 | 0.6 | GO:0032344 | regulation of aldosterone metabolic process(GO:0032344) |
0.1 | 0.7 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 4.4 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.6 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.1 | 0.6 | GO:1904426 | positive regulation of GTP binding(GO:1904426) regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
0.1 | 2.4 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 2.4 | GO:0001967 | suckling behavior(GO:0001967) |
0.1 | 7.8 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.1 | 3.3 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 2.0 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 2.0 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 3.2 | GO:0019395 | fatty acid oxidation(GO:0019395) |
0.1 | 0.3 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.1 | 0.3 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.1 | 0.6 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
0.1 | 0.7 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 0.4 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 1.4 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.1 | 0.5 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.1 | 4.6 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.1 | 0.8 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 2.8 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.8 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 3.2 | GO:1901264 | carbohydrate derivative transport(GO:1901264) |
0.1 | 1.7 | GO:0072010 | glomerular epithelium development(GO:0072010) |
0.1 | 0.7 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.1 | 0.8 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.1 | 0.7 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.1 | GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway(GO:0090081) regulation of heart induction by canonical Wnt signaling pathway(GO:0100012) |
0.1 | 1.7 | GO:0015695 | organic cation transport(GO:0015695) |
0.1 | 0.8 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
0.1 | 1.4 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.8 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.1 | 0.6 | GO:0051012 | microtubule sliding(GO:0051012) |
0.1 | 1.5 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 1.0 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.1 | 0.6 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 0.6 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 0.9 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.1 | 1.1 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.1 | 9.7 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.6 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 0.4 | GO:0019085 | early viral transcription(GO:0019085) |
0.1 | 0.5 | GO:0061056 | sclerotome development(GO:0061056) |
0.1 | 2.5 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.1 | 0.2 | GO:0033280 | response to vitamin D(GO:0033280) |
0.1 | 0.4 | GO:0048209 | regulation of vesicle targeting, to, from or within Golgi(GO:0048209) |
0.1 | 0.5 | GO:0009814 | defense response, incompatible interaction(GO:0009814) defense response to bacterium, incompatible interaction(GO:0009816) regulation of defense response to bacterium, incompatible interaction(GO:1902477) |
0.1 | 8.3 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.1 | 0.8 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.1 | 1.3 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 0.4 | GO:0016240 | autophagosome docking(GO:0016240) |
0.1 | 1.4 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
0.1 | 1.2 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 1.8 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.1 | 1.0 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.1 | 0.3 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.1 | 1.5 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.1 | 0.2 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
0.1 | 0.8 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.1 | 0.9 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
0.1 | 4.0 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.1 | 1.8 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.1 | 0.3 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.1 | 2.4 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.1 | 0.5 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.1 | 0.4 | GO:0072014 | proximal tubule development(GO:0072014) |
0.1 | 1.2 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 0.5 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.3 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.1 | 0.6 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.1 | 0.4 | GO:0060800 | astrocyte fate commitment(GO:0060018) regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.1 | 0.6 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 0.7 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.5 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.1 | 0.9 | GO:0061525 | hindgut development(GO:0061525) |
0.1 | 0.8 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 1.0 | GO:0021678 | third ventricle development(GO:0021678) |
0.1 | 0.4 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 3.5 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.7 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.1 | 0.5 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.1 | 0.4 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.1 | 0.2 | GO:1905024 | regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905024) |
0.1 | 3.1 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 1.0 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.4 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 0.3 | GO:0030473 | nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) nuclear migration along microfilament(GO:0031022) |
0.1 | 0.4 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 0.5 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.1 | 0.9 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 1.9 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 1.5 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.1 | 6.9 | GO:0007586 | digestion(GO:0007586) |
0.1 | 0.3 | GO:0007521 | muscle cell fate determination(GO:0007521) |
0.1 | 0.6 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.1 | 0.6 | GO:0098963 | dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
0.1 | 0.6 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.8 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.6 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.1 | 1.0 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.6 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 0.3 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.1 | 0.7 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.1 | 1.4 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.1 | 1.1 | GO:2001273 | regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.1 | 2.1 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.1 | GO:1904956 | Wnt signaling pathway involved in somitogenesis(GO:0090244) regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
0.1 | 0.9 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.1 | 1.2 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.1 | 1.3 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.1 | 0.3 | GO:0051715 | cytolysis in other organism(GO:0051715) |
0.1 | 1.0 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
0.1 | 0.3 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 1.7 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.1 | 2.4 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 1.6 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.2 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.1 | 1.9 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.1 | 0.3 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.4 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.1 | 0.4 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 0.3 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 2.8 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 0.4 | GO:1990839 | response to endothelin(GO:1990839) |
0.1 | 0.3 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.1 | 0.8 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.1 | 0.2 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.1 | 0.3 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 | 0.5 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.1 | 1.0 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 0.3 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 1.3 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.2 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.1 | 3.7 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 2.3 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.1 | 0.6 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 0.4 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.1 | 0.3 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.1 | 0.8 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.1 | 1.7 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.1 | 0.3 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.1 | 1.1 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.1 | 1.0 | GO:0006206 | pyrimidine nucleobase metabolic process(GO:0006206) |
0.1 | 0.8 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 3.3 | GO:0035690 | cellular response to drug(GO:0035690) |
0.1 | 0.2 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
0.1 | 0.2 | GO:0002159 | desmosome assembly(GO:0002159) |
0.1 | 1.7 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.1 | 0.7 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.8 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.8 | GO:0006110 | regulation of glycolytic process(GO:0006110) regulation of nucleotide catabolic process(GO:0030811) |
0.1 | 0.3 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.1 | 0.6 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.4 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 0.4 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.1 | 1.7 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.1 | 0.4 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.1 | 0.3 | GO:0060462 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
0.1 | 3.6 | GO:0048663 | neuron fate commitment(GO:0048663) |
0.1 | 0.3 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.1 | 0.5 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.1 | 2.2 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 0.1 | GO:0051197 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.1 | 0.4 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.1 | 0.4 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.1 | 2.4 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.1 | 0.6 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.1 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 0.4 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.9 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 1.0 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 0.5 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.2 | GO:0043056 | forward locomotion(GO:0043056) |
0.1 | 0.2 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.2 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.1 | 0.5 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 | 0.2 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 0.5 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 3.2 | GO:0009166 | nucleotide catabolic process(GO:0009166) |
0.1 | 0.9 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 0.1 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.1 | 1.8 | GO:0006818 | hydrogen transport(GO:0006818) |
0.1 | 2.6 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.1 | 0.6 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.1 | 0.5 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.3 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.1 | 0.8 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.4 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.5 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.1 | 0.5 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 2.0 | GO:0070206 | protein trimerization(GO:0070206) |
0.1 | 0.1 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.0 | 0.4 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 4.8 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.0 | 0.1 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.0 | 4.5 | GO:0007601 | visual perception(GO:0007601) |
0.0 | 0.1 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
0.0 | 0.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.3 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 | 0.2 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.3 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.0 | 0.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) coenzyme transport(GO:0051182) |
0.0 | 0.4 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.0 | 3.3 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.3 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.0 | 0.4 | GO:0034776 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
0.0 | 0.1 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.0 | 0.6 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.0 | 0.2 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.0 | 0.1 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.0 | 4.4 | GO:0006486 | protein glycosylation(GO:0006486) macromolecule glycosylation(GO:0043413) |
0.0 | 1.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 1.5 | GO:0046324 | regulation of glucose import(GO:0046324) |
0.0 | 0.2 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.5 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.0 | 0.5 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.2 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.0 | 0.4 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.0 | 0.7 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.0 | 0.3 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.0 | 0.8 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.0 | 0.3 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.0 | 0.5 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.4 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.0 | 0.5 | GO:0001502 | cartilage condensation(GO:0001502) |
0.0 | 0.5 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.0 | 0.5 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.1 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.4 | GO:0003179 | heart valve morphogenesis(GO:0003179) |
0.0 | 2.1 | GO:0042303 | molting cycle(GO:0042303) hair cycle(GO:0042633) |
0.0 | 0.3 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.0 | 0.3 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.0 | 1.3 | GO:0007041 | lysosomal transport(GO:0007041) |
0.0 | 1.0 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
0.0 | 1.0 | GO:0036294 | cellular response to decreased oxygen levels(GO:0036294) cellular response to hypoxia(GO:0071456) |
0.0 | 0.2 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.0 | 0.3 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.3 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.0 | 0.3 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.2 | GO:0046323 | glucose import(GO:0046323) |
0.0 | 0.1 | GO:0032472 | cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) Golgi calcium ion transport(GO:0032472) manganese ion homeostasis(GO:0055071) |
0.0 | 0.3 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.0 | 0.2 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.0 | 0.2 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.0 | 0.4 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.0 | 0.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.3 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.0 | 0.2 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.0 | 1.6 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.0 | 0.4 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 0.4 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
0.0 | 0.9 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.0 | 0.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.2 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.0 | 2.2 | GO:0031668 | cellular response to extracellular stimulus(GO:0031668) |
0.0 | 0.4 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.3 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.5 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.0 | 0.5 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.0 | 0.4 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.3 | GO:0046931 | pore complex assembly(GO:0046931) nuclear pore complex assembly(GO:0051292) |
0.0 | 0.2 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.0 | 0.1 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.0 | 0.6 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 0.2 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.0 | 0.3 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.0 | 0.7 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.1 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.0 | 0.2 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.0 | 0.4 | GO:0023058 | adaptation of signaling pathway(GO:0023058) |
0.0 | 0.1 | GO:1900150 | regulation of defense response to fungus(GO:1900150) |
0.0 | 0.3 | GO:0000338 | protein deneddylation(GO:0000338) |
0.0 | 0.7 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.0 | 0.4 | GO:0030325 | adrenal gland development(GO:0030325) |
0.0 | 0.2 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.0 | 0.4 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.1 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.0 | 0.2 | GO:0030238 | male sex determination(GO:0030238) |
0.0 | 0.4 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.1 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.0 | 0.7 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.0 | 0.1 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.0 | 0.1 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.0 | 0.2 | GO:0061377 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.0 | 0.1 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.0 | 0.3 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 0.1 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.0 | 0.1 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.0 | GO:0031590 | wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
0.0 | 0.0 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.0 | 0.4 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.0 | 1.0 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.4 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.6 | 22.9 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
2.9 | 26.0 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
2.7 | 60.0 | GO:0042627 | chylomicron(GO:0042627) |
2.5 | 7.4 | GO:0044317 | rod spherule(GO:0044317) |
1.6 | 17.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.4 | 5.7 | GO:0045273 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
1.2 | 4.8 | GO:0097447 | dendritic tree(GO:0097447) |
1.2 | 4.6 | GO:0044316 | cone cell pedicle(GO:0044316) |
1.0 | 11.2 | GO:0005579 | membrane attack complex(GO:0005579) |
0.8 | 2.5 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.8 | 5.8 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.8 | 8.9 | GO:0045275 | respiratory chain complex III(GO:0045275) |
0.7 | 0.7 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.7 | 2.0 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.6 | 2.5 | GO:1990429 | Pex17p-Pex14p docking complex(GO:1990415) peroxisomal importomer complex(GO:1990429) |
0.6 | 6.0 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.6 | 1.7 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.5 | 3.8 | GO:0005796 | Golgi lumen(GO:0005796) |
0.5 | 4.8 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.5 | 2.1 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.5 | 3.2 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.5 | 6.8 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.5 | 2.1 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.5 | 3.1 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.5 | 3.6 | GO:0001652 | granular component(GO:0001652) |
0.5 | 1.0 | GO:0032010 | phagolysosome(GO:0032010) |
0.5 | 24.0 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.5 | 2.0 | GO:0097598 | sperm cytoplasmic droplet(GO:0097598) |
0.5 | 1.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.5 | 2.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.5 | 10.0 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.4 | 2.2 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.4 | 5.8 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.4 | 7.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.4 | 1.2 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.4 | 1.6 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.4 | 1.6 | GO:0036019 | endolysosome(GO:0036019) |
0.4 | 1.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.4 | 10.6 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.4 | 1.9 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.4 | 2.9 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.4 | 7.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.4 | 1.1 | GO:0098855 | HCN channel complex(GO:0098855) |
0.4 | 2.1 | GO:0097443 | sorting endosome(GO:0097443) |
0.3 | 3.8 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.3 | 1.0 | GO:0097637 | intrinsic component of autophagosome membrane(GO:0097636) integral component of autophagosome membrane(GO:0097637) |
0.3 | 1.7 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.3 | 2.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.3 | 2.0 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.3 | 1.7 | GO:1990037 | Lewy body core(GO:1990037) |
0.3 | 4.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.3 | 42.4 | GO:0072562 | blood microparticle(GO:0072562) |
0.3 | 3.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.3 | 1.5 | GO:0097427 | microtubule bundle(GO:0097427) |
0.3 | 7.4 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.3 | 4.2 | GO:0043203 | axon hillock(GO:0043203) |
0.3 | 2.2 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.3 | 1.9 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.3 | 1.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.3 | 1.1 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
0.3 | 1.9 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.3 | 3.7 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.3 | 0.8 | GO:0018444 | translation release factor complex(GO:0018444) |
0.3 | 4.5 | GO:0042599 | lamellar body(GO:0042599) |
0.2 | 9.7 | GO:0030673 | axolemma(GO:0030673) |
0.2 | 2.2 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 1.5 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.2 | 3.9 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.2 | 0.7 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.2 | 13.7 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 0.9 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.2 | 1.6 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.2 | 2.3 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 2.7 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.2 | 0.9 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.2 | 0.2 | GO:0070069 | cytochrome complex(GO:0070069) |
0.2 | 4.4 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.2 | 1.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 6.4 | GO:0070469 | respiratory chain(GO:0070469) |
0.2 | 0.6 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 0.9 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.2 | 1.3 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.2 | 0.6 | GO:0005713 | recombination nodule(GO:0005713) |
0.2 | 8.1 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.2 | 6.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 2.7 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 2.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.2 | 2.2 | GO:0045179 | apical cortex(GO:0045179) |
0.2 | 1.0 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.2 | 0.8 | GO:0044393 | microspike(GO:0044393) |
0.2 | 1.6 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.2 | 3.2 | GO:0045180 | basal cortex(GO:0045180) |
0.2 | 8.9 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 0.8 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.2 | 9.6 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.2 | 15.0 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 0.7 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 0.6 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.2 | 0.7 | GO:0071942 | XPC complex(GO:0071942) |
0.2 | 8.7 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.2 | 1.6 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.2 | 0.9 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) COPII vesicle coat(GO:0030127) |
0.2 | 0.4 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.2 | 0.7 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 1.9 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 1.4 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.2 | 1.4 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.2 | 0.5 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.2 | 0.5 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.2 | 0.7 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 33.9 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.2 | 0.5 | GO:0032437 | cuticular plate(GO:0032437) |
0.2 | 1.4 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.2 | 5.0 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 46.6 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.2 | 59.8 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.2 | 2.4 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.1 | 0.3 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
0.1 | 0.4 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 1.6 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 0.6 | GO:1990796 | lateral part of cell(GO:0097574) basolateral part of cell(GO:1990794) rod bipolar cell terminal bouton(GO:1990795) photoreceptor cell terminal bouton(GO:1990796) |
0.1 | 1.4 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.9 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 232.9 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 2.6 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 1.5 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 0.4 | GO:0099631 | postsynaptic endocytic zone cytoplasmic component(GO:0099631) |
0.1 | 2.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 1.0 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 0.7 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 1.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.6 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 0.5 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 1.1 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.4 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 0.6 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 1.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.9 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 1.0 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 3.1 | GO:0031300 | intrinsic component of organelle membrane(GO:0031300) |
0.1 | 0.7 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.8 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 1.0 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 0.3 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
0.1 | 0.9 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.6 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 2.1 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.5 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.7 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 1.7 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.1 | 0.8 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 4.8 | GO:0000791 | euchromatin(GO:0000791) |
0.1 | 2.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.8 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 0.6 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.1 | 0.4 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.1 | 1.6 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 1.2 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 1.8 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.3 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.3 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 0.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 0.4 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 1.2 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 0.1 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 0.5 | GO:0097227 | sperm annulus(GO:0097227) |
0.1 | 0.5 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 2.1 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.2 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
0.0 | 0.4 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 0.5 | GO:0071437 | invadopodium(GO:0071437) |
0.0 | 0.5 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.4 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.0 | 0.5 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.0 | 0.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 1.0 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.0 | 0.3 | GO:0030897 | HOPS complex(GO:0030897) |
0.0 | 0.1 | GO:0035841 | new growing cell tip(GO:0035841) |
0.0 | 0.5 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.0 | 0.3 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 3.1 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 4.9 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.5 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.3 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.3 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.2 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 1.8 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.3 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 3.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.8 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.3 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 0.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.4 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.2 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 0.1 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 1.5 | GO:0045177 | apical part of cell(GO:0045177) |
0.0 | 0.1 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.0 | 0.2 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 0.1 | GO:0071565 | nBAF complex(GO:0071565) |
0.0 | 0.2 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) oxoglutarate dehydrogenase complex(GO:0045252) |
0.0 | 1.8 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.2 | GO:0034706 | voltage-gated sodium channel complex(GO:0001518) sodium channel complex(GO:0034706) |
0.0 | 0.1 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 1.0 | GO:0005770 | late endosome(GO:0005770) |
0.0 | 0.1 | GO:0070187 | telosome(GO:0070187) |
0.0 | 0.5 | GO:0045171 | intercellular bridge(GO:0045171) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.0 | 24.0 | GO:0052871 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) |
7.0 | 20.9 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
6.8 | 13.6 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
5.5 | 5.5 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
4.4 | 8.9 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
4.0 | 20.1 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
3.9 | 15.5 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
3.8 | 30.0 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
2.9 | 14.6 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
2.8 | 11.3 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
2.6 | 13.0 | GO:0004925 | prolactin receptor activity(GO:0004925) |
2.6 | 7.7 | GO:0005186 | pheromone activity(GO:0005186) |
2.6 | 10.3 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
2.3 | 2.3 | GO:0004998 | transferrin receptor activity(GO:0004998) |
2.3 | 9.2 | GO:0042806 | fucose binding(GO:0042806) |
2.3 | 9.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
2.0 | 8.0 | GO:0015232 | heme transporter activity(GO:0015232) |
2.0 | 6.0 | GO:0004063 | aryldialkylphosphatase activity(GO:0004063) |
1.9 | 5.8 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
1.9 | 28.8 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
1.9 | 5.7 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
1.9 | 5.6 | GO:0003979 | UDP-glucose 6-dehydrogenase activity(GO:0003979) |
1.8 | 7.4 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
1.7 | 5.0 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
1.6 | 4.9 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
1.6 | 6.5 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
1.6 | 9.8 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
1.6 | 9.8 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
1.6 | 1.6 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
1.6 | 4.7 | GO:0031403 | lithium ion binding(GO:0031403) |
1.6 | 10.9 | GO:0001851 | complement component C3b binding(GO:0001851) |
1.5 | 4.6 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
1.4 | 36.9 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
1.3 | 4.0 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
1.3 | 4.0 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
1.3 | 4.0 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
1.3 | 6.6 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
1.3 | 3.9 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
1.3 | 11.7 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
1.3 | 3.8 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
1.3 | 2.5 | GO:0070404 | NADH binding(GO:0070404) |
1.2 | 7.4 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
1.2 | 7.3 | GO:0004359 | glutaminase activity(GO:0004359) |
1.2 | 4.8 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.2 | 3.5 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
1.2 | 3.5 | GO:0050479 | glyceryl-ether monooxygenase activity(GO:0050479) |
1.1 | 3.4 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
1.1 | 9.1 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
1.1 | 8.0 | GO:0072510 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
1.1 | 3.3 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
1.1 | 4.4 | GO:0004058 | aromatic-L-amino-acid decarboxylase activity(GO:0004058) L-dopa decarboxylase activity(GO:0036468) |
1.1 | 4.2 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.1 | 6.3 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
1.0 | 6.3 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
1.0 | 4.2 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
1.0 | 4.0 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
1.0 | 4.0 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
1.0 | 2.9 | GO:0048039 | ubiquinone binding(GO:0048039) |
1.0 | 2.9 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
1.0 | 4.9 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
1.0 | 3.9 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
1.0 | 2.9 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.9 | 2.8 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.9 | 22.2 | GO:0005550 | pheromone binding(GO:0005550) |
0.9 | 2.7 | GO:0004454 | ketohexokinase activity(GO:0004454) |
0.9 | 3.5 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.9 | 12.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.9 | 2.6 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.8 | 3.4 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.8 | 3.4 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.8 | 2.5 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.8 | 3.3 | GO:0050436 | microfibril binding(GO:0050436) |
0.8 | 0.8 | GO:0071820 | N-box binding(GO:0071820) |
0.8 | 2.5 | GO:0008431 | vitamin E binding(GO:0008431) |
0.8 | 11.0 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.8 | 2.3 | GO:0004560 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.8 | 2.3 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.8 | 9.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.7 | 3.7 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.7 | 3.0 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.7 | 3.0 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
0.7 | 3.0 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.7 | 2.2 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.7 | 27.6 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.7 | 3.6 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.7 | 1.4 | GO:0032564 | dATP binding(GO:0032564) |
0.7 | 2.2 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) |
0.7 | 5.7 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.7 | 7.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.7 | 6.4 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.7 | 18.1 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.7 | 2.8 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.7 | 2.1 | GO:0008940 | nitrate reductase activity(GO:0008940) |
0.7 | 2.7 | GO:0030984 | kininogen binding(GO:0030984) |
0.7 | 6.1 | GO:0001846 | opsonin binding(GO:0001846) |
0.7 | 2.0 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.7 | 4.0 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.7 | 1.3 | GO:0004921 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
0.7 | 6.5 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.7 | 2.0 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.6 | 3.8 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.6 | 8.3 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.6 | 6.4 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.6 | 1.9 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.6 | 2.5 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.6 | 5.0 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.6 | 3.1 | GO:0070012 | oligopeptidase activity(GO:0070012) |
0.6 | 1.9 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.6 | 2.5 | GO:0050632 | propanoyl-CoA C-acyltransferase activity(GO:0033814) propionyl-CoA C2-trimethyltridecanoyltransferase activity(GO:0050632) phosphatidylethanolamine transporter activity(GO:1904121) |
0.6 | 4.9 | GO:0035473 | lipase binding(GO:0035473) |
0.6 | 6.7 | GO:0001848 | complement binding(GO:0001848) |
0.6 | 4.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.6 | 4.7 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.6 | 1.8 | GO:0030614 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
0.6 | 1.8 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.6 | 2.3 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.6 | 1.7 | GO:0036478 | tyrosine 3-monooxygenase activator activity(GO:0036470) L-dopa decarboxylase activator activity(GO:0036478) |
0.6 | 2.2 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.6 | 3.3 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.5 | 2.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.5 | 2.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.5 | 2.2 | GO:0047726 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
0.5 | 4.9 | GO:0031419 | cobalamin binding(GO:0031419) |
0.5 | 1.6 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.5 | 3.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.5 | 1.6 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
0.5 | 1.6 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
0.5 | 5.3 | GO:0043426 | MRF binding(GO:0043426) |
0.5 | 2.6 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) D-glucose transmembrane transporter activity(GO:0055056) |
0.5 | 1.6 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
0.5 | 3.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.5 | 3.6 | GO:0005534 | galactose binding(GO:0005534) |
0.5 | 2.5 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.5 | 4.0 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.5 | 1.5 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.5 | 2.5 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.5 | 3.5 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.5 | 2.0 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
0.5 | 1.5 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.5 | 1.9 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.5 | 9.2 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.5 | 2.4 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.5 | 1.9 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
0.5 | 1.4 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.5 | 4.1 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.5 | 2.3 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.5 | 1.4 | GO:0035605 | peptidyl-cysteine S-nitrosylase activity(GO:0035605) |
0.5 | 1.8 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.4 | 5.8 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.4 | 4.9 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.4 | 7.7 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.4 | 6.8 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.4 | 0.9 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.4 | 1.3 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
0.4 | 1.7 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.4 | 1.3 | GO:0047651 | hydrolase activity, acting on acid halide bonds(GO:0016824) hydrolase activity, acting on acid halide bonds, in C-halide compounds(GO:0019120) alkylhalidase activity(GO:0047651) |
0.4 | 7.6 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.4 | 1.3 | GO:0072541 | peroxynitrite reductase activity(GO:0072541) |
0.4 | 12.0 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.4 | 2.1 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.4 | 3.3 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.4 | 4.5 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.4 | 1.2 | GO:0030977 | taurine binding(GO:0030977) |
0.4 | 7.2 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.4 | 4.0 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.4 | 2.0 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.4 | 1.6 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.4 | 3.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.4 | 3.9 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.4 | 1.9 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
0.4 | 1.9 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.4 | 1.9 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.4 | 1.9 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.4 | 2.2 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.4 | 1.1 | GO:0051747 | cytosine C-5 DNA demethylase activity(GO:0051747) |
0.4 | 1.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.4 | 2.9 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.4 | 1.1 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.4 | 7.1 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.4 | 2.5 | GO:0039706 | co-receptor binding(GO:0039706) |
0.4 | 2.5 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.4 | 1.4 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.4 | 2.1 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.3 | 2.4 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.3 | 2.4 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.3 | 0.7 | GO:0032190 | acrosin binding(GO:0032190) |
0.3 | 2.4 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.3 | 1.4 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.3 | 2.4 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.3 | 1.3 | GO:0034618 | arginine binding(GO:0034618) |
0.3 | 1.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.3 | 6.0 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.3 | 1.7 | GO:0010181 | FMN binding(GO:0010181) |
0.3 | 7.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.3 | 6.5 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.3 | 5.2 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.3 | 2.3 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.3 | 1.6 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.3 | 1.6 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.3 | 1.0 | GO:0019778 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
0.3 | 3.8 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.3 | 6.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.3 | 1.6 | GO:0038051 | glucocorticoid receptor activity(GO:0004883) transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.3 | 2.8 | GO:0070061 | fructose binding(GO:0070061) |
0.3 | 2.2 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.3 | 4.7 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.3 | 0.9 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.3 | 48.3 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.3 | 1.5 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.3 | 1.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.3 | 14.1 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.3 | 1.8 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.3 | 2.0 | GO:0089720 | caspase binding(GO:0089720) |
0.3 | 0.8 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
0.3 | 1.7 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.3 | 0.8 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.3 | 1.7 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.3 | 1.9 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.3 | 6.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.3 | 0.8 | GO:0070736 | protein-glycine ligase activity, initiating(GO:0070736) |
0.3 | 2.1 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.3 | 1.3 | GO:0032810 | sterol response element binding(GO:0032810) |
0.3 | 0.3 | GO:0048030 | disaccharide binding(GO:0048030) |
0.3 | 0.5 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.3 | 1.1 | GO:0043758 | acetate-CoA ligase (ADP-forming) activity(GO:0043758) |
0.3 | 4.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.3 | 3.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.3 | 10.2 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.3 | 2.1 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.3 | 2.6 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.3 | 0.8 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.3 | 3.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.3 | 7.1 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.2 | 6.7 | GO:0008009 | chemokine activity(GO:0008009) |
0.2 | 0.5 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.2 | 1.0 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.2 | 6.2 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.2 | 1.7 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.2 | 3.5 | GO:0043176 | amine binding(GO:0043176) |
0.2 | 0.9 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) |
0.2 | 0.7 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.2 | 0.7 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.2 | 8.1 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 1.7 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.2 | 0.7 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
0.2 | 2.4 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.2 | 0.9 | GO:0036033 | mediator complex binding(GO:0036033) |
0.2 | 0.6 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.2 | 1.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 18.0 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.2 | 1.9 | GO:0070402 | NADPH binding(GO:0070402) |
0.2 | 3.1 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.2 | 3.5 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.2 | 4.7 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.2 | 2.4 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.2 | 6.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 2.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 1.9 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.2 | 0.6 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.2 | 1.9 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.2 | 3.4 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.2 | 3.4 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.2 | 0.6 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.2 | 0.7 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.2 | 4.0 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 4.0 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.2 | 3.0 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.2 | 2.9 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.2 | 1.1 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.2 | 0.7 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.2 | 2.1 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.2 | 0.5 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.2 | 3.1 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 1.0 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.2 | 1.0 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.2 | 1.5 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.2 | 2.5 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.2 | 4.4 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.2 | 0.8 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.2 | 1.8 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.2 | 0.8 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) IkappaB kinase activity(GO:0008384) |
0.2 | 0.5 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
0.2 | 6.4 | GO:0030552 | cAMP binding(GO:0030552) |
0.2 | 2.1 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.2 | 6.4 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.2 | 0.2 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.2 | 3.5 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.2 | 12.8 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.2 | 3.0 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.2 | 2.3 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.1 | 4.9 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 1.9 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.4 | GO:0035939 | microsatellite binding(GO:0035939) |
0.1 | 0.7 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.7 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.1 | 0.9 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 0.6 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.1 | 2.0 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 1.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.7 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 2.8 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 0.4 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.1 | 1.8 | GO:0004579 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.5 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.1 | 1.2 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.1 | 0.4 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.1 | 2.6 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.4 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.1 | 0.4 | GO:0004816 | asparagine-tRNA ligase activity(GO:0004816) |
0.1 | 1.6 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 0.5 | GO:1990269 | RNA polymerase II C-terminal domain phosphoserine binding(GO:1990269) |
0.1 | 0.8 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.3 | GO:0050997 | quaternary ammonium group binding(GO:0050997) |
0.1 | 0.8 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.1 | 1.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.5 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 1.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.8 | GO:0043398 | HLH domain binding(GO:0043398) |
0.1 | 1.8 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 1.6 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 2.8 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 4.2 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.1 | 3.2 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 0.6 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 1.8 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 1.2 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 1.0 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.3 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
0.1 | 0.8 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 4.1 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.1 | 14.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.3 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 1.6 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 0.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 1.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.1 | GO:1904047 | S-adenosyl-L-methionine binding(GO:1904047) |
0.1 | 2.1 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 0.7 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 1.4 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.3 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.5 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.1 | 0.7 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 0.7 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 0.4 | GO:0051381 | histamine binding(GO:0051381) |
0.1 | 0.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 1.0 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.1 | 2.3 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 1.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.3 | GO:1990955 | G-rich single-stranded DNA binding(GO:1990955) |
0.1 | 4.0 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.9 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 8.5 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.1 | 1.3 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.1 | 9.3 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 0.7 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.1 | 0.8 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.1 | 0.4 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.1 | 0.5 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 0.8 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.7 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.4 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 0.7 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 0.3 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.1 | 0.3 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.1 | 1.5 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.8 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 1.1 | GO:0004559 | alpha-mannosidase activity(GO:0004559) mannosidase activity(GO:0015923) |
0.1 | 0.4 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 2.7 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 0.4 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.1 | 0.4 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.2 | GO:0098639 | protein binding involved in cell-matrix adhesion(GO:0098634) collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 0.2 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 2.4 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.1 | 0.5 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.1 | 0.3 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) ankyrin repeat binding(GO:0071532) |
0.1 | 1.0 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 8.3 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 0.5 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.1 | 0.9 | GO:0009055 | electron carrier activity(GO:0009055) |
0.1 | 2.9 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.3 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.4 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 0.8 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.5 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 2.0 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.1 | 1.0 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 0.8 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.1 | 0.5 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.6 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.1 | 0.3 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 0.5 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.1 | 2.0 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.1 | 0.1 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 1.5 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 1.0 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 0.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 1.5 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.1 | 0.4 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.1 | 0.6 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 1.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.4 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.7 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 5.8 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 1.2 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.1 | 2.6 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 0.6 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.3 | GO:0034432 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
0.1 | 1.9 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 1.6 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.7 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.1 | 0.3 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.1 | 0.4 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.6 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.9 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.4 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 2.9 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.1 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.7 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 1.0 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.7 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.7 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 0.3 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.5 | GO:0031402 | sodium ion binding(GO:0031402) |
0.0 | 2.0 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 1.9 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 2.6 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.0 | 1.8 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 1.6 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 2.5 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.3 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.0 | 1.0 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.9 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 1.1 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 2.6 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.3 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.0 | 1.1 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 1.4 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.0 | 0.6 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 0.4 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 1.1 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 1.0 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.0 | 8.1 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.5 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.7 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 1.1 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 1.0 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.8 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.1 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.0 | 0.1 | GO:0015410 | manganese-transporting ATPase activity(GO:0015410) |
0.0 | 0.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.3 | GO:0043855 | cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.7 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.2 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.0 | 0.6 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.3 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.5 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.2 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.0 | 0.2 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.0 | 0.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.4 | GO:0051536 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.0 | 0.2 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.0 | 0.2 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.3 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.0 | 0.3 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
0.0 | 0.5 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.5 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 2.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.3 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.5 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.0 | 1.0 | GO:0008186 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.0 | 0.5 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 0.2 | GO:0052744 | phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
0.0 | 0.4 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.2 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.0 | 1.4 | GO:0015293 | symporter activity(GO:0015293) |
0.0 | 0.1 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 0.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.4 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.1 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.0 | 1.6 | GO:0017137 | Rab GTPase binding(GO:0017137) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 2.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.5 | 6.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.5 | 9.0 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.4 | 20.3 | PID IGF1 PATHWAY | IGF1 pathway |
0.3 | 2.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.3 | 20.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.3 | 0.8 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.3 | 10.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.2 | 5.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 10.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.2 | 12.7 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.2 | 9.6 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.2 | 2.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 10.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 9.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 1.7 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.2 | 1.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.9 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 7.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 3.8 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 3.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 3.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 3.9 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 1.0 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 2.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 2.9 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 3.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 0.3 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 2.8 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 4.7 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 1.8 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 0.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 1.7 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 1.7 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 2.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 1.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 1.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 16.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 1.8 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 1.6 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 1.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 1.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 1.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 0.9 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 3.8 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 1.7 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 9.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 2.9 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 2.2 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 1.6 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.6 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.9 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 1.8 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.3 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 1.3 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 1.4 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 1.4 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.3 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.9 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 2.3 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.5 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 3.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.5 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.5 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.3 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.1 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.1 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 5.5 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
1.6 | 42.7 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
1.5 | 23.0 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
1.4 | 4.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
1.4 | 10.9 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
1.2 | 7.5 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
1.1 | 14.1 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
1.1 | 13.7 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
1.0 | 9.6 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.9 | 19.0 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.7 | 1.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.7 | 14.0 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.7 | 2.0 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.6 | 43.6 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.6 | 24.3 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.6 | 6.5 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.5 | 12.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.5 | 8.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.5 | 7.6 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.5 | 6.8 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.5 | 7.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.4 | 4.0 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.4 | 2.6 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.4 | 5.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.4 | 7.1 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.4 | 3.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.4 | 2.9 | REACTOME OPSINS | Genes involved in Opsins |
0.4 | 4.6 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.4 | 6.0 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.3 | 6.4 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.3 | 4.0 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.3 | 4.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.3 | 5.7 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.3 | 4.6 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.3 | 2.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.3 | 3.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.3 | 0.9 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.3 | 0.9 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.3 | 4.9 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.3 | 5.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.3 | 54.5 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.3 | 2.3 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.2 | 15.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.2 | 22.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 6.9 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.2 | 0.9 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 6.2 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.2 | 1.9 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.2 | 4.5 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.2 | 1.0 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.2 | 2.8 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.2 | 3.9 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 5.8 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.2 | 1.9 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.2 | 3.3 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.2 | 1.7 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.2 | 1.7 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.2 | 3.2 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.2 | 1.8 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.2 | 1.9 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.2 | 2.8 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 1.6 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 4.0 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 5.1 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.1 | 4.9 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 1.8 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 2.9 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 2.6 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 3.3 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 0.9 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.1 | 0.3 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 7.0 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.1 | 2.0 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 0.5 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 7.4 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 1.6 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 1.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 4.0 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 2.8 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 2.1 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 1.2 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.1 | 1.8 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 1.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 2.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 1.9 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 1.1 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 0.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 2.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.9 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 0.7 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 3.2 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.1 | 1.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 1.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 1.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 1.0 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 0.9 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 0.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.8 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.1 | 1.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 1.1 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.1 | 0.6 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 0.7 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 1.4 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 0.6 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 0.2 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.1 | 1.0 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 0.5 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 1.0 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.1 | 1.0 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 1.1 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.1 | 1.3 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.8 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.0 | 1.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 1.4 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.6 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.0 | 0.6 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.6 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 2.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 1.7 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.4 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 1.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 1.1 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.5 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.4 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.4 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.0 | 1.2 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.3 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.1 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.0 | 1.2 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.7 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 1.5 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.3 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.0 | 0.1 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.9 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.0 | 1.1 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.9 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.0 | 0.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.5 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.1 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |